Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group study.

MLA

Lamm, D. L., et al. “Randomized Intergroup Comparison of Bacillus Calmette-Guerin Immunotherapy and Mitomycin C Chemotherapy Prophylaxis in Superficial Transitional Cell Carcinoma of the Bladder a Southwest Oncology Group Study.” Urologic Oncology, vol. 1, no. 3, May 1995, pp. 119–26. EBSCOhost, https://doi.org/10.1016/1078-1439(95)00041-f.

APA

Lamm, D. L., Blumenstein, B. A., David Crawford, E., Crissman, J. D., Lowe, B. A., Smith, J. A., Jr, Sarosdy, M. F., Schellhammer, P. F., Sagalowsky, A. I., Messing, E. M., Loehrer, P., & Barton Grossman, H. (1995). Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group study. Urologic Oncology, 1(3), 119–126. https://doi.org/10.1016/1078-1439(95)00041-f

Chicago

Lamm, D L, B A Blumenstein, E David Crawford, J D Crissman, B A Lowe, J A Smith Jr, M F Sarosdy, et al. 1995. “Randomized Intergroup Comparison of Bacillus Calmette-Guerin Immunotherapy and Mitomycin C Chemotherapy Prophylaxis in Superficial Transitional Cell Carcinoma of the Bladder a Southwest Oncology Group Study.” Urologic Oncology 1 (3): 119–26. doi:10.1016/1078-1439(95)00041-f.